Mr. Mongrain has more than 18 years of financial experience centered on technology, growth-oriented businesses. During his 9 years in Entrepreneurial Services and Mergers & Acquisitions at Ernst & Young, he worked with several entrepreneurs in high-growth companies. Through these years, Mr. Mongrain was instrumental in more than 12 start-ups and participated in several IPO and private placements for young emerging companies. Following his Ernst & Young years, he became a founding partner of BridgeCapital Inc., a private consulting firm offering strategic and financial expertise to technology venture companies.
Prior to Mimetogen, Mr. Mongrain co-founded Innodia, a biotech company focusing its R&D activity in developing novel drugs for the treatment of diabetes and obesity. As Vice-President of Finance & CFO and then Chief Operating Officer, he successfully financed the company’s research & development operations over a six-year period prior to orchestrating the sell of the company to a public-listed Canadian biotechnology company.
Francois received a Bachelor of Commerce degree from the Ecole des Hautes Etudes Commerciales (Montreal) and earned his Charted Accountant designation with Ernst & Young in 1993.
The Orchestra 
